TEL, B. C. Et Al. 2021. Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study. JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.3 , 352-358.

TEL, B. C., KAZKAYASI, İ., TELLİ, G., Cinar, E., Mutluay, S. U., YALÇIN ÇAKMAKLI, G., ... SAKA TOPÇUOĞLU, E.(2021). Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study. JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.3, 352-358.

TEL, BANU Et Al. "Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study," JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.3, 352-358, 2021

TEL, BANU C. Et Al. "Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study." JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.3, pp.352-358, 2021

TEL, B. C. Et Al. (2021) . "Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study." JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.3, pp.352-358.

@article{article, author={BANU CAHİDE TEL Et Al. }, title={Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A time-course study}, journal={JOURNAL OF RESEARCH IN PHARMACY}, year=2021, pages={352-358} }